Yamasaki, Keisuke
Hata, Jun http://orcid.org/0000-0003-2698-344X
Ide, Tomomi
Nagata, Takuya
Sakata, Satoko
Yoshida, Daigo
Honda, Takanori
Hirakawa, Yoichiro
Nakano, Toshiaki
Kitazono, Takanari
Tsutsui, Hiroyuki
Ninomiya, Toshiharu
Funding for this research was provided by:
Ministry of Education, Culture, Sports, Science and Technology (JP16H02692, JP17H04126, JP18H02737, JP19H03863, JP18K07565, JP18K09412, JP19K07890, JP20K10503, JP20K11020, JP18K17925, JP19K23971)
Ministry of Health, Labour and Welfare (20FA1002)
Japan Agency for Medical Research and Development (JP20dk0207025, JP20km0405202, JP20fk0108075)
Article History
Received: 4 March 2021
Accepted: 4 April 2021
First Online: 12 April 2021
Declarations
:
: This study was conducted with the approval of the Kyushu University Institutional Board for Clinical Research. Written informed consent was obtained from all subjects.
: Not applicable.
: Hiroyuki Tsutsui reports grants and personal fees from Daiichi Sankyo Co., Ltd., Mitsubishi Tanabe Pharma Corporation, and Nippon Boehringer Ingelheim Co., Ltd.; grants from IQVIA Services Japan, Omron Healthcare, and MEDINET Co., Ltd.; and personal fees from AstraZeneca K.K., Ono Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Teijin Pharma Ltd., Novartis Pharma K.K., Bayer Yakuhin, Ltd., Pfizer Japan Inc., Bristol-Myers Squibb Company, Kowa Company, Limited, and Nippon Rinsho, outside the submitted work. The other authors declare that they have no competing interests.